Professor Paul Griffin

So in an ideal situation, we'd have all the resources, expertise, PPE, et cetera, to the region to contain this before a vaccine's available.

But for many of the reasons we've discussed and many others, that may not necessarily be successful.

So working on a vaccine will be a really important part of this response.

And there's two or three lead candidates already, and we're

very lucky to have organisations like the Coalition for Epidemic Preparedness Innovations who are supporting, coordinating and funding this sort of work because it's not something that unfortunately is viable for private companies to really fund.

But we've got that work happening and so hopefully we'll have a vaccine relatively soon.

But obviously, as happened with COVID and other new vaccines, has to go through all the necessary stages of clinical trials to be deployed.

So we're talking many months before that's likely to be available.

Thank you.